These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 23077289)

  • 1. The high Nrf2 expression in human acute myeloid leukemia is driven by NF-κB and underlies its chemo-resistance.
    Rushworth SA; Zaitseva L; Murray MY; Shah NM; Bowles KM; MacEwan DJ
    Blood; 2012 Dec; 120(26):5188-98. PubMed ID: 23077289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HO-1 underlies resistance of AML cells to TNF-induced apoptosis.
    Rushworth SA; MacEwan DJ
    Blood; 2008 Apr; 111(7):3793-801. PubMed ID: 18202225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of NF-E2 related factor 2 (Nrf2) on chemotherapy resistance in acute myeloid leukemia (AML) and the effect of pharmacological inhibition of Nrf2.
    Karathedath S; Rajamani BM; Musheer Aalam SM; Abraham A; Varatharajan S; Krishnamurthy P; Mathews V; Velayudhan SR; Balasubramanian P
    PLoS One; 2017; 12(5):e0177227. PubMed ID: 28505160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NRF2-driven miR-125B1 and miR-29B1 transcriptional regulation controls a novel anti-apoptotic miRNA regulatory network for AML survival.
    Shah NM; Zaitseva L; Bowles KM; MacEwan DJ; Rushworth SA
    Cell Death Differ; 2015 Apr; 22(4):654-64. PubMed ID: 25323587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nrf2 overexpression increases the resistance of acute myeloid leukemia to cytarabine by inhibiting replication factor C4.
    Hu T; Pan C; Zhang T; Ni M; Wang W; Zhang S; Chen Y; Wang J; Fang Q
    Cancer Gene Ther; 2022 Nov; 29(11):1773-1790. PubMed ID: 35840666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High basal nuclear levels of Nrf2 in acute myeloid leukemia reduces sensitivity to proteasome inhibitors.
    Rushworth SA; Bowles KM; MacEwan DJ
    Cancer Res; 2011 Mar; 71(5):1999-2009. PubMed ID: 21212410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disulfiram/copper selectively eradicates AML leukemia stem cells in vitro and in vivo by simultaneous induction of ROS-JNK and inhibition of NF-κB and Nrf2.
    Xu B; Wang S; Li R; Chen K; He L; Deng M; Kannappan V; Zha J; Dong H; Wang W
    Cell Death Dis; 2017 May; 8(5):e2797. PubMed ID: 28518151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antineoplastic mechanisms of niclosamide in acute myelogenous leukemia stem cells: inactivation of the NF-kappaB pathway and generation of reactive oxygen species.
    Jin Y; Lu Z; Ding K; Li J; Du X; Chen C; Sun X; Wu Y; Zhou J; Pan J
    Cancer Res; 2010 Mar; 70(6):2516-27. PubMed ID: 20215516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-inhibition of NF-κB and JNK is synergistic in TNF-expressing human AML.
    Volk A; Li J; Xin J; You D; Zhang J; Liu X; Xiao Y; Breslin P; Li Z; Wei W; Schmidt R; Li X; Zhang Z; Kuo PC; Nand S; Zhang J; Chen J; Zhang J
    J Exp Med; 2014 Jun; 211(6):1093-108. PubMed ID: 24842373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of NRF2 signaling overcomes acquired resistance to arsenic trioxide in FLT3-mutated Acute Myeloid Leukemia.
    Jebanesan DZP; Illangeswaran RSS; Rajamani BM; Vidhyadharan RT; Das S; Bijukumar NK; Balakrishnan B; Mathews V; Velayudhan SR; Balasubramanian P
    Ann Hematol; 2024 Jun; 103(6):1919-1929. PubMed ID: 38630133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NF-kappaB-inhibited acute myeloid leukemia cells are rescued from apoptosis by heme oxygenase-1 induction.
    Rushworth SA; Bowles KM; Raninga P; MacEwan DJ
    Cancer Res; 2010 Apr; 70(7):2973-83. PubMed ID: 20332229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NF-κB and Keap1 Interaction Represses Nrf2-Mediated Antioxidant Response in Rabbit Hemorrhagic Disease Virus Infection.
    Hu B; Wei H; Song Y; Chen M; Fan Z; Qiu R; Zhu W; Xu W; Wang F
    J Virol; 2020 May; 94(10):. PubMed ID: 32161178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mechanism of Tibetan medicine Ershiwuwei Songshi Pills against liver injury induced by acetaminophen in mice based on Keap1/Nrf2 and TLR4/NF-κB p65 signaling pathways].
    Sha YR; Luo XM; Ding Y; Yang B; Jian CF; Gong PY; Gu J; Tan R
    Zhongguo Zhong Yao Za Zhi; 2022 Apr; 47(8):2049-2055. PubMed ID: 35531720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dihydromyricetin reverses MRP2-induced multidrug resistance by preventing NF-κB-Nrf2 signaling in colorectal cancer cell.
    Wang Z; Sun X; Feng Y; Wang Y; Zhang L; Wang Y; Fang Z; Azami NLB; Sun M; Li Q
    Phytomedicine; 2021 Feb; 82():153414. PubMed ID: 33461143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of PIM-2 and NF-κB genes is increased in patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) and is associated with complete remission rate and overall survival.
    Kapelko-Słowik K; Urbaniak-Kujda D; Wołowiec D; Jaźwiec B; Dybko J; Jakubaszko J; Słowik M; Kuliczkowski K
    Postepy Hig Med Dosw (Online); 2013 Jun; 67():553-9. PubMed ID: 23752607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Nrf2 transcription factor is a positive regulator of myeloid differentiation of acute myeloid leukemia cells.
    Bobilev I; Novik V; Levi I; Shpilberg O; Levy J; Sharoni Y; Studzinski GP; Danilenko M
    Cancer Biol Ther; 2011 Feb; 11(3):317-29. PubMed ID: 21099366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bortezomib sensitivity of acute myeloid leukemia CD34(+) cells can be enhanced by targeting the persisting activity of NF-κB and the accumulation of MCL-1.
    Bosman MC; Schuringa JJ; Quax WJ; Vellenga E
    Exp Hematol; 2013 Jun; 41(6):530-538.e1. PubMed ID: 23416210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The eukaryotic translation initiation factor eIF4E is a direct transcriptional target of NF-κB and is aberrantly regulated in acute myeloid leukemia.
    Hariri F; Arguello M; Volpon L; Culjkovic-Kraljacic B; Nielsen TH; Hiscott J; Mann KK; Borden KL
    Leukemia; 2013 Oct; 27(10):2047-55. PubMed ID: 23467026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The deubiquitinase USP15 modulates cellular redox and is a therapeutic target in acute myeloid leukemia.
    Niederkorn M; Ishikawa C; M Hueneman K; Bartram J; Stepanchick E; R Bennett J; E Culver-Cochran A; Bolanos LC; Uible E; Choi K; Wunderlich M; Perentesis JP; M Chlon T; Filippi MD; Starczynowski DT
    Leukemia; 2022 Feb; 36(2):438-451. PubMed ID: 34465865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcription factors NRF2 and NF-κB are coordinated effectors of the Rho family, GTP-binding protein RAC1 during inflammation.
    Cuadrado A; Martín-Moldes Z; Ye J; Lastres-Becker I
    J Biol Chem; 2014 May; 289(22):15244-58. PubMed ID: 24759106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.